verified SJR 0,553 · Q2 • database Scopus / SJR indexed

United States · Begell House Inc.

workspace_premium Q2 — Cancer Research lock Subscription

Critical Reviews in Oncogenesis

Critical Reviews in Oncogenesis is a journal indexed in SJR in Cancer Research with an H index of 59. It has an SJR impact factor of 0,553 and it has a best quartile of Q2. It is published in English. It has an SJR impact factor of 0,553.

ISSN: 0893-9675

Publisher: Begell House Inc.

Category: Cancer Research

Indexation: verifiedScopus / SJR

open_in_new Portal NPD menu_book Guidelines NPD

schedule CountryOfPapers database fields

SJR Impact Factor trending_up

0,553 Q2

H-index 59

Acceptance rate pie_chart

30% Selective

Source Acceptance_Rate

Time to publication hourglass_top

NPD

Field NPD

Publication cost (APC) payments

NPD Subscription

Non-OA path NPD

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR

SJR Impact

0,553

H-index

Docs (year)

Docs 3y

Total refs

2541

Cites 3y

106

Citable 3y

Cites/Doc 2y

1.31

Ref/Doc

77.0

Immediate OA

—

Embargoed OA

NPD

Non OA / Submission

—

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims

rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID * * Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Current Status of Radiosensitizing Agents for the Management of Rectal Cancer

YY1 in Cell Differentiation and Tissue Development

Gene Fusions in Human Cancers: A Review Focused on Diagnostic Biomarkers, Method Selections, and Treatments

Gemcitabine: A Review of Chemoresistance in Pancreatic Cancer

Essential Role of Angiogenic Factors and Bone Marrow-Derived Endothelial/Hematopoietic Cells in the Growth of Solid Tumors

Epigenetic Modifications and Modulators in Prostate Cancer

Engaging Cell Death Pathways for the Treatment of Rhabdomyosarcoma

Emerging Technologies for Genome-wide DNA Methylation Profiling in Cancer

Drug Combinations with HDAC Inhibitors in Antitumor Therapy

Downregulation of Gap Junctions in Cancer Cells

Dietary Flavonoid and Cancer Prevention: Evidence and Potential Mechanism

Development of Nanoscale Approaches for Ovarian Cancer Therapeutics and Diagnostics

SHOW MORE ARTICLES

Current Status of Surgical Intervention for the Management of Rectal Cancer

Aging and Cancer Vaccines

Current Status of Radiation Therapy for the Management of Rectal Cancer

Current State of Knowledge on Salivary Gland Cancers

Critical Concepts in the Oncogenesis of Adenocarcionoma of the Rectum

Counteracting Inflammation: A Promising Therapy in Cachexia

Commentary on Lynch Syndrome and Related Familial Colorectal Cancers

Cancer Stem Cells, Their Microenvironment and Anoikis

Cancer Stem Cells in Urooncology

Cancer and Cancer Stem Cells: New Molecular Perspectives

Biomarkers of DNA Repair and Related Pathways: Significance of Treatment in Triple-Negative Breast Cancer

Biology of Rectal Cancer-The Rationale for Targeted Therapy

FAQs

Critical Reviews in Oncogenesis has an SJR of 0,553 (best quartile Q2) in the CountryOfPapers database.

Immediate OA APC is not available (NPD).

The acceptance rate recorded for Critical Reviews in Oncogenesis is 30%.

Critical Reviews in Oncogenesis

Metrics

Name good journals. Call out predatory ones.

Researcher reviews

Best articles by citations

FAQs

What is the SJR of Critical Reviews in Oncogenesis?

What is the APC / publication cost?

What is the acceptance rate?